 n the long-term interest of Alligator. In the 
selection of performance criteria, the strategic objectives and 
short-term and long-term business priorities for 2024 have been 
taken into account. The non-financial performance measures 
further contribute to alignment with sustainability as well as 
Alligator’s values.
Table 3 – Performance of the CEO in the reported financial year: variable cash remuneration
1 2 3
Name of director 
(position)Description of the criteria related to the 
remuneration componentRelative weighting of the performance 
criteriaa) Measured performance; and 
b) actual award / remuneration outcome
Søren Bregenholt 
(CEO)Financing/ 
partner agreements20%a) 10% 
b) KSEK 113
Development of/ 
progress in the clinical programs80%a) 40% 
b) KSEK 449

5
Remuneration report | Alligator Bioscience AB | Remuneration Report 2024Comparative information on the change of remuneration and Alligator’s performance
Table 4 – Change of remuneration and Alligator’s performance over